J Cancer 2023; 14(11):2066-2074. doi:10.7150/jca.86683 This issue Cite

Review

Lipid metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy

Hui Liu1†, Xiuming Li2†, Yajie Dong1, Changhua Zhou3, Caidan Rezeng4,5✉

1. Chengde Medical University, Chengde, China, Hebei 067000, China.
2. Department of Urology, Affiliated Hospital of Chengde Medical University, Hebei 067000, China.
3. Department of Pediatrics, Chengde County Hospital of Traditional Chinese Medicine, Hebei 067000, China.
4. School of Pharmacy, Qinghai University for Nationalities, Qinghai, 810000, China.
5. Engineering Research Center for Pharmaceutics of Chinese Materia Medica and New Drug Development, Ministry of Education, Beijing 100029, China.
†These authors have contributed equally to this work.

Citation:
Liu H, Li X, Dong Y, Zhou C, Rezeng C. Lipid metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. J Cancer 2023; 14(11):2066-2074. doi:10.7150/jca.86683. https://www.jcancer.org/v14p2066.htm
Other styles

File import instruction

Abstract

Graphic abstract

Epidemiological data have shown a positive correlation between lipid levels and tumor occurrence, such as the correlation between tumor frequency and aggressiveness, and cardiovascular disease, obesity, type 2 diabetes mellitus, and hyperinsulinemia. Therefore, reducing fat accumulation or weakening lipid metabolism may affect the carcinogenic processes of cells. Many studies have shown that traditional Chinese Medicine (TCM) has obvious advantages over traditional therapies in terms of fewer side effects, lower toxicity, and lower economic burden. This paper reviews the mechanism by which TCM regulates lipid metabolism and its antitumor effect through this regulation, with the aim of elucidating the bioactive compounds in TCM with good efficacy and few side effects that can provide promising therapeutic drugs for targeting lipid metabolism reprogramming in cancer.

Keywords: Traditional Chinese medicine, TCM, tumor, lipid metabolism reprogramming, cancer therapy


Citation styles

APA
Liu, H., Li, X., Dong, Y., Zhou, C., Rezeng, C. (2023). Lipid metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Journal of Cancer, 14(11), 2066-2074. https://doi.org/10.7150/jca.86683.

ACS
Liu, H.; Li, X.; Dong, Y.; Zhou, C.; Rezeng, C. Lipid metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. J. Cancer 2023, 14 (11), 2066-2074. DOI: 10.7150/jca.86683.

NLM
Liu H, Li X, Dong Y, Zhou C, Rezeng C. Lipid metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. J Cancer 2023; 14(11):2066-2074. doi:10.7150/jca.86683. https://www.jcancer.org/v14p2066.htm

CSE
Liu H, Li X, Dong Y, Zhou C, Rezeng C. 2023. Lipid metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. J Cancer. 14(11):2066-2074.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image